PI
Pharmstandard International Portfolio holdings
AUM
$29M
1-Year Return
2.12%
This Quarter Return
-20.33%
1 Year Return
+2.12%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$35.2M
AUM Growth
-$53.6M
(-60%)
Cap. Flow
+$14.5M
Cap. Flow
% of AUM
41.35%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
+$14.6M |
Top Sells
| 1 |
Protagonist Therapeutics
PTGX
|
+$16.7K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNCE
1
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $14.6M | 38.85% |
+662,063
| New | +$14.6M |
|
|
2
Protagonist Therapeutics
PTGX
$3.66B
| $12.6M | 33.57% |
982,270
-1,300
| -0.1% | -$16.7K |
|
|
ARGS
3
DELISTED
Argos Therapeutics, Inc.
ARGS
| $5.98M | 15.97% |
662,114
| – | – |
|
4
Protara Therapeutics
TARA
$121M
| $2.04M | 5.44% |
29,134
| – | – |
|